Nexera Mikros
Supporting Micro Flowrate Range Liquid Chromatography Mass Spectrometry System
The High Sensitivity You Expect from a Low Flow System with the Ruggedness of HPLC Covering the Complete Range from Micro to Semi-Micro
Improvement in the sensitivity of an LC/MS/MS method can generally be achieved by reducing the analytical scale of the analysis. However, reducing the analytical scale significantly to nano-flow reduces the throughput, stability, and robustness as a trade-off for greater sensitivity. Nexera Mikros, a Shimadzu microflow LC/MS system, offers a balanced solution to increased sensitivity with less compromise to throughput and robustness, using flow rates from 1 to 500 μL/min and column I.D. from 0.1 to 1 mm. It achieves stable and sensitive quantitative analysis through robust performance of microflow solvent delivery, optimized ion source design, the unique UF-Link column connection, and system variety that supports a wide range of applications.
Features
News / Events
-
Latest issue of Shimadzu Journal, featuring Environmental Analysis, has come out.
This issue showcases advanced technologies and research tackling the global challenges posed by PFAS. As part of Shimadzu’s ongoing commitment to sustainability and problem solving, we strive to reduce environmental impacts and build a better future.
-
New High Resolution Accurate Mass Library for Forensic Toxicology
Perform forensic toxicology screening for drugs of abuse, psychotropic drugs, pharmaceuticals, pesticides, and natural toxins using this high-resolution accurate mass database.
-
Shimadzu has released the Shim-vial™ H glass, S glass.
Shimadzu provides high-quality vials that thoroughly eliminate these risks by visually inspecting each vial, allowing them to be used with confidence.
-
INTERNATIONAL MASS SPECTROMETRY CONFERENCE 2024
Visit the Shimadzu booth at the International Mass Spectrometry Conference (IMSC) 2024.
-
Metabolomics 2024
Shimadzu Lunch Presentation at Metabolomics 2024
Date: June 20th, 2024 (Thursday)
Time: 12:25 – 1:25 p.m. -
New LabSolutions Insight Biologics
Supporting Innovation with Oligonucleotide Therapeutics